Circulating tumor cells in prostate cancer diagnosis and monitoring

An appraisal of clinical potential

Giuseppe Galletti, Luigi Portella, Scott T. Tagawa, Brian J. Kirby, Paraskevi Giannakakou, David M. Nanus

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.

Original languageEnglish
Pages (from-to)389-402
Number of pages14
JournalMolecular Diagnosis and Therapy
Volume18
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Circulating Neoplastic Cells
Prostatic Neoplasms
Neoplasms
Biomarkers
Biopsy
Population

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Medicine(all)
  • Pharmacology

Cite this

Circulating tumor cells in prostate cancer diagnosis and monitoring : An appraisal of clinical potential. / Galletti, Giuseppe; Portella, Luigi; Tagawa, Scott T.; Kirby, Brian J.; Giannakakou, Paraskevi; Nanus, David M.

In: Molecular Diagnosis and Therapy, Vol. 18, No. 4, 2014, p. 389-402.

Research output: Contribution to journalArticle

Galletti, Giuseppe ; Portella, Luigi ; Tagawa, Scott T. ; Kirby, Brian J. ; Giannakakou, Paraskevi ; Nanus, David M. / Circulating tumor cells in prostate cancer diagnosis and monitoring : An appraisal of clinical potential. In: Molecular Diagnosis and Therapy. 2014 ; Vol. 18, No. 4. pp. 389-402.
@article{97a43f34ce724528bd2f3ae8a26c21f6,
title = "Circulating tumor cells in prostate cancer diagnosis and monitoring: An appraisal of clinical potential",
abstract = "Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.",
author = "Giuseppe Galletti and Luigi Portella and Tagawa, {Scott T.} and Kirby, {Brian J.} and Paraskevi Giannakakou and Nanus, {David M.}",
year = "2014",
doi = "10.1007/s40291-014-0101-8",
language = "English",
volume = "18",
pages = "389--402",
journal = "Molecular Diagnosis and Therapy",
issn = "1177-1062",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Circulating tumor cells in prostate cancer diagnosis and monitoring

T2 - An appraisal of clinical potential

AU - Galletti, Giuseppe

AU - Portella, Luigi

AU - Tagawa, Scott T.

AU - Kirby, Brian J.

AU - Giannakakou, Paraskevi

AU - Nanus, David M.

PY - 2014

Y1 - 2014

N2 - Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.

AB - Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.

UR - http://www.scopus.com/inward/record.url?scp=84905683195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905683195&partnerID=8YFLogxK

U2 - 10.1007/s40291-014-0101-8

DO - 10.1007/s40291-014-0101-8

M3 - Article

VL - 18

SP - 389

EP - 402

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

SN - 1177-1062

IS - 4

ER -